US2013150258A1PendingUtilityA1

Prognosis and therapy predictive markers and methods of use

54
Assignee: UNIV CHICAGOPriority: Jan 19, 2006Filed: Jan 4, 2013Published: Jun 13, 2013
Est. expiryJan 19, 2026(expired)· nominal 20-yr term from priority
Inventors:Ralph R. WeichselbaumBernard RoizmanAndy MinnNikolai KhodarevEdwardine Labay
G01N 33/57557G01N 33/5758C12Q 1/6886C12Q 2600/106C12Q 2600/112C12Q 2600/118G01N 2800/52
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a set of genes differentially expressed in chemotherapy and radiation resistant tumors useful in predicting response to therapy and assessing risk of local-regional failure, survival and metastasis in cancer patients. Also disclosed are methods for characterizing tumors according to gene expression and kits for use in the methods of the invention.

Claims

exact text as granted — not AI-modified
1 . A method of characterizing a tumor from a patient comprising detecting expression of at least one IRDS marker by the tumor. 
     
     
         2 - 28 . (canceled)

Join the waitlist — get patent alerts

Track US2013150258A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.